Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease—Methodology and Clinical Applications

Tanja Diana; George J. Kahaly

doi:10.1097/iop.0000000000001053

journal article Jul 01, 2018

Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease—Methodology and Clinical Applications

Tanja Diana George J. Kahaly

Ophthalmic Plastic & Reconstructive Surgery Vol. 34 No. 4S pp. S13-S19 · Ovid Technologies (Wolters Kluwer Health)

View at Publisher Save 10.1097/iop.0000000000001053

Abstract

Background:
Thyroid stimulating hormone receptor antibodies (TSHR-Ab) cause autoimmune hyperthyroidism and are prevalent in patients with related thyroid eye disease (TED).

Purpose:
To provide a historical perspective on TSHR-Ab and to present evidence-based recommendations for clinical contemporary use.

Methods:
The authors review the recent literature pertaining to TSHR-Ab in patients with TED and describe the various immunoassays currently used for detecting TSHR-Ab and their clinical applications.

Results:
We provide a historical summary and description of the various methods used to detect TSHR-Ab, foremost, the functional TSHR-Ab. Increasing experimental and clinical data demonstrate the clinical usefulness of cell-based bioassays for measurements of functional TSHR-Ab in the diagnosis and management of patients with autoimmune TED and in the characterization of patients with autoimmune-induced hyperthyroidism and hypothyroidism. Thyroid stimulating hormone receptor antibodies, especially the functional stimulating antibodies, are sensitive, specific, and reproducible biomarkers for patients with autoimmune TED and correlate well with clinical disease activity and clinical severity. Unlike competitive-binding assays, bioassays have the advantage of indicating not only the presence of antibodies but also their functional activity and potency.

Conclusions:
Measurement of TSHR-Ab (especially stimulating antibodies) is a clinically useful tool for the management of patients with TED.

Topics

No keywords indexed for this article. Browse by subject →

References

67

[1]

Kahaly "Graves’ Disease." N Engl J Med (2017) 10.1056/nejmc1614624

[2]

Brent "Clinical practice. Graves’ disease." N Engl J Med (2008) 10.1056/nejmcp0801880

[3]

Weetman "Graves’ disease." N Engl J Med (2000) 10.1056/nejm200010263431707

[4]

Kahaly "The thyrocyte-fibrocyte link: closing the loop in the pathogenesis of Graves’ disease?" J Clin Endocrinol Metab (2010) 10.1210/jc.2009-2405

[5]

Graves' Ophthalmopathy

Rebecca S. Bahn

New England Journal of Medicine 2010 10.1056/nejmra0905750

[6]

Hansen "HPLC glycosaminoglycan analysis in patients with Graves’ disease." Clin Sci (Lond) (1997) 10.1042/cs0920511

[7]

Hansen "Increased sulfatation of orbital glycosaminoglycans in Graves’ ophthalmopathy." J Clin Endocrinol Metab (1999)

[8]

Kahaly "Urinary glycosaminoglycans in Graves’ ophthalmopathy." Clin Endocrinol (Oxf) (1990) 10.1111/j.1365-2265.1990.tb00463.x

[9]

Kahaly "Glycosaminoglycans in thyroid-associated ophthalmopathy." Autoimmunity (1992) 10.3109/08916939209014639

[10]

Förster "Analysis of orbital T cells in thyroid-associated ophthalmopathy." Clin Exp Immunol (1998) 10.1046/j.1365-2249.1998.00613.x

[11]

Kahaly "Regulatory T-cells in Graves’ orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin." J Clin Endocrinol Metab (2011) 10.1210/jc.2010-1424

[12]

Laurberg "TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study." Eur J Endocrinol (2008) 10.1530/eje-07-0450

[13]

Massart "Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves’ disease: comparison with the second generation human TRAb assay." Clin Chim Acta (2009) 10.1016/j.cca.2009.06.033

[14]

Kahaly "TSH receptor antibody functionality and nomenclature." Front Endocrinol (Lausanne) (2017) 10.3389/fendo.2017.00028

[15]

Smith "TSH receptor antibodies." Thyroid (2007) 10.1089/thy.2007.0239

[16]

Smith "Thyroid-stimulating immunoglobulins in Graves’ disease." Lancet (1974) 10.1016/s0140-6736(74)91815-7

[17]

Shewring "An improved radioreceptor assay for TSH receptor antibodies." Clin Endocrinol (Oxf) (1982) 10.1111/j.1365-2265.1982.tb01607.x

[18]

Sanders "The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor." J Clin Endocrinol Metab (1999) 10.1210/jcem.84.10.6071

[19]

Costagliola "Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves’ disease." J Clin Endocrinol Metab (1999)

[20]

Bolton "Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA." Clin Chem (1999) 10.1093/clinchem/45.12.2285

[21]

Ando "Thyrotropin receptor antibodies: new insights into their actions and clinical relevance." Best Pract Res Clin Endocrinol Metab (2005) 10.1016/j.beem.2004.11.005

[22]

Gassner "First automated assay for thyrotropin receptor autoantibodies." Clin Chem Lab Med (2009) 10.1515/cclm.2009.245

[23]

Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies

Derik Hermsen, Martina Broecker-Preuss, Marco Casati et al.

Clinica Chimica Acta 2009 10.1016/j.cca.2008.11.025

[24]

Schott "Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease (GD): an international multicentre trial." Clin Endocrinol (Oxf) (2009) 10.1111/j.1365-2265.2008.03512.x

[25]

Kamijo "Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves’ disease." Thyroid (2011) 10.1089/thy.2011.0056

[26]

Rahhal "Thyroid stimulating immunoglobulin is often negative in children with Graves’ disease." J Pediatr Endocrinol Metab (2008) 10.1515/jpem.2008.21.11.1085

[27]

Botero "Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves disease." J Pediatr (1998) 10.1016/s0022-3476(98)70348-8

[28]

Shibayama "Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves’ disease." Endocr J (2005) 10.1507/endocrj.52.505

[29]

Lytton "Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins." Clin Exp Immunol (2010) 10.1111/j.1365-2249.2010.04266.x

[30]

Takasu "Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves’ disease." Clin Exp Pharmacol Physiol (2004) 10.1111/j.1440-1681.2004.03991.x

[31]

Uno "[Clinical studies on abnormal thyroid stimulators in patients with Graves’ disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves’ disease and patients with hyperthyroid Graves’ disease during antithyroid drug treatment]." Nihon Naibunpi Gakkai Zasshi (1988)

[32]

Kim "Thyroid-stimulating antibody assay using a human thyrotropin receptor transfected cell line: relationship to clinical features of graves’ disease." Endocr Pract (1997) 10.4158/ep.3.6.337

[33]

Smith "TSH receptor antibodies." Thyroid (2007) 10.1089/thy.2007.0239

[34]

Rees Smith "TSH receptor - autoantibody interactions." Horm Metab Res (2009) 10.1055/s-0029-1220913

[35]

Lytton "Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins." Clin Exp Immunol (2010) 10.1111/j.1365-2249.2010.04266.x

[36]

Pierce "Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor-guanine nucleotide-binding protein, (GNAS) fusion bioassay." Clin Exp Immunol (2012) 10.1111/j.1365-2249.2012.04648.x

[37]

Araki "Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin." Eur Thyroid J (2015) 10.1159/000371740

[38]

Parmentier "Molecular cloning of the thyrotropin receptor." Science (1989) 10.1126/science.2556796

[39]

Perret "Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones." Biochem Biophys Res Commun (1990) 10.1016/0006-291x(90)90789-p

[40]

Morgenthaler "Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor." Horm Metab Res (1998) 10.1055/s-2007-978858

[41]

Takano "Detection of thyroid-stimulating antibody using frozen stocks of Chinese hamster ovary cells transfected with cloned human thyrotropin receptor." Endocr J (1997) 10.1507/endocrj.44.431

[42]

Wallaschofski "Detection of thyroid stimulating (TSAB)- and thyrotropin stimulation blocking (TSBAB) antibodies with CHO cell lines expressing different TSH-receptor numbers." Clin Endocrinol (Oxf) (1999) 10.1046/j.1365-2265.1999.00672.x

[43]

Watson "A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves’ disease." Clin Endocrinol (Oxf) (1998) 10.1046/j.1365-2265.1998.00619.x

[44]

Himmler "Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines." J Recept Res (1993) 10.3109/10799899309073647

[45]

Evans "Development of a luminescent bioassay for thyroid stimulating antibodies." J Clin Endocrinol Metab (1999) 10.1210/jcem.84.1.5532

[46]

Tahara "Immunoglobulins from Graves’ disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients." Biochem Biophys Res Commun (1991) 10.1016/0006-291x(91)91335-a

[47]

Giuliani "A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in graves’ patients undergoing antithyroid drug (ATD) treatment." J Clin Endocrinol Metab (2012) 10.1210/jc.2011-2897

[48]

Giuliani "A TSHr-LH/CGr chimera that measures functional TSAb in Graves’ disease." J Clin Endocrinol Metab (2012) 10.1210/jc.2011-2893

[49]

Lytton "A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves’ orbitopathy." J Clin Endocrinol Metab (2010) 10.1210/jc.2009-2470

[50]

Kumar "A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves’ ophthalmopathy." J Mol Endocrinol (2011) 10.1530/jme-11-0006

Showing 50 of 67 references

Cited By

56

Thyrotropin receptor antibodies and Graves’ orbitopathy

T. Diana, K. A. Ponto · 2020

Journal of Endocrinological Investi...

Metrics

56

Citations

67

References

Details

Published: Jul 01, 2018
Vol/Issue: 34(4S)
Pages: S13-S19

Authors

T

Tanja Diana

Department of Medicine I, Molecular Thyroid Research Laboratory, Johannes Gutenberg University (JGU) Medical Center, Mainz, Germany

G

George J. Kahaly

Department of Medicine I, Molecular Thyroid Research Laboratory, Johannes Gutenberg University (JGU) Medical Center, Mainz, Germany

Cite This Article

Tanja Diana, George J. Kahaly (2018). Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease—Methodology and Clinical Applications. Ophthalmic Plastic & Reconstructive Surgery, 34(4S), S13-S19. https://doi.org/10.1097/iop.0000000000001053

Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease—Methodology and Clinical Applications

You May Also Like